Arterys Inc., a company focused on medical imaging, has announced the close of its Series A financing, bringing the total round to $12 million.
The funding will be used to expand the commercial operations of the company’s visualization and quantification algorithm for medical imaging.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Cardiovascular disease is the number one cause of death in the U.S., but there currently isn’t a non-invasive diagnostic tool beyond the echocardiogram, which lacks blood flow accuracy.
Areterys software connects to an MRI machine to allow non-invasive, precise quantitation of blood flow quickly leveraging the latest technologies in cloud computation. After receiving an 10-minute MRI scan, a patient’s data is sent to a HIPAA-compliant cloud server for computational analysis via a simple web browser.
GE Ventures, the Stanford-StartX Fund (which was co-founded by the StartX accelerator, Stanford University and Stanford Health Care) and Norwich Ventures join Emergent Medical Partners who led the round, with additional participation by existing investors Asset Management Ventures, AME Cloud Ventures and Morado Ventures.
The Arterys System will be commercially available globally to the thousands of installed and new GE Healthcare MRI scanners through the application called ViosWorks in the fall of 2016.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Photo: Screenshot via Arterys
